Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.

McColley, S A; Stellmach, V; Boas, S R; Jain, M; Crawford, S E

McColley, S A; Stellmach, V; Boas, S R; Jain, M; Crawford, S E.

Affiliation

McColley SA; Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA. smccolley@nwu.edu

Am J Respir Crit Care Med ; 161(6): 1877-80, 2000 Jun.

Article in En | MEDLINE | ID: mdl-10852760

Subject(s)

Anti-Bacterial Agents/therapeutic use; Cystic Fibrosis/blood; Endothelial Growth Factors/blood; Lymphokines/blood; Pneumonia, Bacterial/blood; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis/drug therapy; Disease Progression; Female; Forced Expiratory Volume/drug effects; Forced Expiratory Volume/physiology; Humans; Lung/blood supply; Male; Middle Aged; Neovascularization, Pathologic/blood; Pneumonia, Bacterial/drug therapy; Pseudomonas Infections/blood; Pseudomonas Infections/drug therapy; Pseudomonas aeruginosa/drug effects; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Endothelial Growth Factors / Lymphokines / Pneumonia, Bacterial / Cystic Fibrosis / Anti-Bacterial Agents Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2000 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links